Implementation of a standardized clinical pathway in a dedicated posterior urethral valves clinic: short-term outcomes.
Clinical pathway
Lower urinary tract obstruction
Pediatrics
Posterior urethral valves
Proactive management
Journal
Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
17
03
2023
accepted:
09
05
2023
revised:
09
05
2023
medline:
22
9
2023
pubmed:
16
6
2023
entrez:
15
6
2023
Statut:
ppublish
Résumé
To determine if the implementation of a posterior urethral valves (PUV) clinic and standardized management pathway improves the short-term kidney outcomes of infants with PUV. From 2016-2022, 50 consecutive patients were divided into groups after the implementation of the clinic (APUV, n = 29) and before (BPUV, n = 21) during a comparable timeframe. Assessed data included age at initial visit, timing and type of surgery, frequency of follow-up visits, medications, nadir creatinine, and development of CKD/kidney failure. Data are shown as median with interquartile range (IQR) and odds ratios (OR) with 95% confidence interval (CI). APUV had higher rates of prenatal diagnoses (12/29 vs. 1/21; p = 0.0037), earlier initial surgical intervention (8 days; IQR 0, 105 vs. 33 days; IQR 4, 603; p < 0.0001), and higher rates of primary diversions (10/29 vs. 0/21; p = 0.0028). Standardized management led to earlier initiation of alpha blockers (326 days; IQR 6, 860 vs. 991; IQR 149, 1634; p = 0.0019) and anticholinergics (57 days; IQR 3, 860 vs. 1283 days; IQR 477, 1718; p < 0.0001). Nadir creatinine was reached at earlier ages in APUV (105 days; IQR 2, 303 vs. 164 days; IQR 21, 447; p = 0.0192 BPUV). One patient progressed to CKD5 in APUV compared to CKD3, CKD5 and one transplant in BPUV. Implementing the PUV clinic with standardized treatment expedited postnatal management and resulted in a higher number of cases detected prenatally, a shift in primary treatment, younger ages at initial treatment, reduced time to nadir creatinine, and timely initiation of supportive medications. A higher resolution version of the Graphical abstract is available as Supplementary information.
Sections du résumé
BACKGROUND
To determine if the implementation of a posterior urethral valves (PUV) clinic and standardized management pathway improves the short-term kidney outcomes of infants with PUV.
METHODS
From 2016-2022, 50 consecutive patients were divided into groups after the implementation of the clinic (APUV, n = 29) and before (BPUV, n = 21) during a comparable timeframe. Assessed data included age at initial visit, timing and type of surgery, frequency of follow-up visits, medications, nadir creatinine, and development of CKD/kidney failure. Data are shown as median with interquartile range (IQR) and odds ratios (OR) with 95% confidence interval (CI).
RESULTS
APUV had higher rates of prenatal diagnoses (12/29 vs. 1/21; p = 0.0037), earlier initial surgical intervention (8 days; IQR 0, 105 vs. 33 days; IQR 4, 603; p < 0.0001), and higher rates of primary diversions (10/29 vs. 0/21; p = 0.0028). Standardized management led to earlier initiation of alpha blockers (326 days; IQR 6, 860 vs. 991; IQR 149, 1634; p = 0.0019) and anticholinergics (57 days; IQR 3, 860 vs. 1283 days; IQR 477, 1718; p < 0.0001). Nadir creatinine was reached at earlier ages in APUV (105 days; IQR 2, 303 vs. 164 days; IQR 21, 447; p = 0.0192 BPUV). One patient progressed to CKD5 in APUV compared to CKD3, CKD5 and one transplant in BPUV.
CONCLUSION
Implementing the PUV clinic with standardized treatment expedited postnatal management and resulted in a higher number of cases detected prenatally, a shift in primary treatment, younger ages at initial treatment, reduced time to nadir creatinine, and timely initiation of supportive medications. A higher resolution version of the Graphical abstract is available as Supplementary information.
Identifiants
pubmed: 37322171
doi: 10.1007/s00467-023-06040-7
pii: 10.1007/s00467-023-06040-7
doi:
Substances chimiques
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3735-3744Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
Références
Heikkilä J, Holmberg C, Kyllönen L et al (2011) Long-term risk of end stage renal disease in patients with posterior urethral valves. J Urol 186:2392–2396. https://doi.org/10.1016/j.juro.2011.07.109
doi: 10.1016/j.juro.2011.07.109
pubmed: 22014822
McLeod DJ, Szymanski KM, Gong E et al (2019) Renal Replacement Therapy and Intermittent Catheterization Risk in Posterior Urethral Valves. Pediatrics 143:e20182656. https://doi.org/10.1542/peds.2018-2656
doi: 10.1542/peds.2018-2656
pubmed: 30709926
Kim SJ, Jung J, Lee C et al (2018) Long-term outcomes of kidney and bladder function in patients with a posterior urethral valve. Medicine 97:e11033. https://doi.org/10.1097/MD.0000000000011033
doi: 10.1097/MD.0000000000011033
pubmed: 29879071
pmcid: 5999499
Pohl M, Mentzel H-J, Vogt S et al (2012) Risk factors for renal insufficiency in children with urethral valves. Pediatr Nephrol 27:443–450. https://doi.org/10.1007/s00467-011-1999-2
doi: 10.1007/s00467-011-1999-2
pubmed: 22009479
Capone V, Persico N, Berrettini A et al (2022) Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group. Nat Rev Urol. https://doi.org/10.1038/s41585-022-00563-8
doi: 10.1038/s41585-022-00563-8
pubmed: 35882995
Fontanella F, Duin LK, Adama van Scheltema PN et al (2018) Prenatal diagnosis of LUTO: improving diagnostic accuracy. Ultrasound Obstet Gynecol 52:739–743. https://doi.org/10.1002/uog.18990
doi: 10.1002/uog.18990
pubmed: 29266464
pmcid: 6587765
Smith GH, Canning DA, Schulman SL et al (1996) The long-term outcome of posterior urethral valves treated with primary valve ablation and observation. J Urol 155:1730–1734
doi: 10.1016/S0022-5347(01)66186-X
pubmed: 8627873
Yadav P, Rickard M, Weaver J et al (2022) Pre-natal vs Post-natal Presentation of PUV: A Multi-institutional Experience. BJU Int. https://doi.org/10.1111/bju.15708
doi: 10.1111/bju.15708
pubmed: 36161751
pmcid: 10262352
Klaus R, Lange-Sperandio B (2022) Chronic Kidney Disease in Boys with Posterior Urethral Valves-Pathogenesis, Prognosis and Management. Biomedicines 10:1894. https://doi.org/10.3390/biomedicines10081894
doi: 10.3390/biomedicines10081894
pubmed: 36009441
pmcid: 9405968
Alsaywid BS, Mohammed AF, Jbril SM et al (2021) Renal outcome among children with posterior urethral valve: When to worry? Urol Ann 13:30–35. https://doi.org/10.4103/UA.UA_112_19
doi: 10.4103/UA.UA_112_19
pubmed: 33897161
Lopez Pereira P, Martinez Urrutia MJ, Espinosa L, Jaureguizar E (2013) Long-term consequences of posterior urethral valves. J Pediatr Urol 9:590–596. https://doi.org/10.1016/j.jpurol.2013.06.007
doi: 10.1016/j.jpurol.2013.06.007
pubmed: 23871421
Kousidis G, Thomas DFM, Morgan H et al (2008) The long-term outcome of prenatally detected posterior urethral valves: a 10 to 23-year follow-up study. BJU Int 102:1020–1024. https://doi.org/10.1111/j.1464-410X.2008.07745.x
doi: 10.1111/j.1464-410X.2008.07745.x
pubmed: 18485035
Keefe DT, Kim JK, Mackay E et al (2021) Predictive accuracy of prenatal ultrasound findings for lower urinary tract obstruction: A systematic review and Bayesian meta-analysis. Prenat Diagn 41:1039–1048. https://doi.org/10.1002/pd.6025
doi: 10.1002/pd.6025
pubmed: 34318486
Varni JW, Burwinkle TM, Seid M, Skarr D (2003) The PedsQLTM* 4.0 as a Pediatric Population Health Measure: Feasibility, Reliability, and Validity. Ambul Pediatr 3:329–341. https://doi.org/10.1367/1539-4409(2003)003%3c0329:TPAAPP%3e2.0.CO;2
doi: 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2
pubmed: 14616041
Farhat W, Bägli DJ, Capolicchio G et al (2000) The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol 164:1011–1015. https://doi.org/10.1016/S0022-5347(05)67239-4
doi: 10.1016/S0022-5347(05)67239-4
pubmed: 10958730
Wood DL, Sawicki GS, Miller MD et al (2014) The Transition Readiness Assessment Questionnaire (TRAQ): Its Factor Structure, Reliability, and Validity. Acad Pediatr 14:415–422. https://doi.org/10.1016/j.acap.2014.03.008
doi: 10.1016/j.acap.2014.03.008
pubmed: 24976354
Schwartz GJ, Muñoz A, Schneider MF et al (2009) New Equations to Estimate GFR in Children with CKD. J Am Soc Nephrol 20:629–637. https://doi.org/10.1681/ASN.2008030287
doi: 10.1681/ASN.2008030287
pubmed: 19158356
pmcid: 2653687
Gurria JP, Simpson B, Tuncel-Kara S et al (2020) Standardization of clinical care pathway leads to sustained decreased length of stay following Nuss pectus repair: A multidisciplinary quality improvement initiative. J Pediatr Surg 55:2690–2698. https://doi.org/10.1016/j.jpedsurg.2020.08.009
doi: 10.1016/j.jpedsurg.2020.08.009
pubmed: 32972738
Lee J, Rodio B, Lavelle J et al (2018) Improving Anaphylaxis Care: The Impact of a Clinical Pathway. Pediatrics 141:e20171616. https://doi.org/10.1542/peds.2017-1616
doi: 10.1542/peds.2017-1616
pubmed: 29615480
Owen JE, Walker RJ, Edgell L et al (2006) Implementation of a pre-dialysis clinical pathway for patients with chronic kidney disease. Int J Qual Health Care 18:145–151. https://doi.org/10.1093/intqhc/mzi094
doi: 10.1093/intqhc/mzi094
pubmed: 16396939
Elliott MJ, Gil S, Hemmelgarn BR et al (2016) A scoping review of adult chronic kidney disease clinical pathways for primary care. Nephrol Dial Transplant 32:848–846. https://doi.org/10.1093/ndt/gfw208
doi: 10.1093/ndt/gfw208
Yadav P, Rickard M, Kim JK et al (2022) Comparison of outcomes of prenatal versus postnatal presentation of posterior urethral valves: a systematic review and meta-analysis. World J Urol. https://doi.org/10.1007/s00345-022-04097-x
doi: 10.1007/s00345-022-04097-x
pubmed: 35943527
Penna FJ, Bowlin P, Alyami F et al (2015) Novel Strategy for Temporary Decompression of the Lower Urinary Tract in Neonates Using a Ureteral Stent. J Urol 194:1086–1090. https://doi.org/10.1016/j.juro.2015.04.102
doi: 10.1016/j.juro.2015.04.102
pubmed: 25963187
Dekirmendjian A, Mcgrath M, Braga LH (2017) Case: Anuria and acute renal failure post-endoscopic valve ablation and Foley catheter insertion in a newborn with a small-capacity, non-compliant bladder. Can Urol Assoc J 11:E382–E384. https://doi.org/10.5489/cuaj.4466
doi: 10.5489/cuaj.4466
pubmed: 29382462
pmcid: 5798444
Khondker A, Kim JK, Chua ME et al (2022) The effect of primary urinary diversion on kidney function in posterior urethral valve: A matched comparison. Urology S0090–4295(22):00993–01001. https://doi.org/10.1016/j.urology.2022.11.022
doi: 10.1016/j.urology.2022.11.022
Gilbert SM, Lai J, Saigal CS et al (2013) Downstream complications following urinary diversion. J Urol 190:916–922. https://doi.org/10.1016/j.juro.2013.03.026
doi: 10.1016/j.juro.2013.03.026
pubmed: 23499749
pmcid: 9901199
Tanagho EA (1974) Congenitally obstructed bladders: fate after prolonged defunctionalization. J Urol 111:102–109. https://doi.org/10.1016/s0022-5347(17)59900-0
doi: 10.1016/s0022-5347(17)59900-0
pubmed: 4205086
Rickard M, Santos JD, Keunen J, Lorenzo AJ (2022) Prenatal Hydronephrosis: Bridging Pre- and Postnatal Management. Prenat Diagn. https://doi.org/10.1002/pd.6114
doi: 10.1002/pd.6114
pubmed: 35165908
Hofmann A, Haider M, Cox A et al (2022) Is Vesicostomy Still a Contemporary Method of Managing Posterior Urethral Valves? Children (Basel) 9:138. https://doi.org/10.3390/children9020138
doi: 10.3390/children9020138
pubmed: 35204859
Godbole P, Wade A, Mushtaq I, Wilcox DT (2007) Vesicostomy vs primary ablation for posterior urethral valves: always a difference in outcome? J Pediatr Urol 3:273–275. https://doi.org/10.1016/j.jpurol.2006.11.007
doi: 10.1016/j.jpurol.2006.11.007
pubmed: 18947754
Podestá ML, Ruarte A, Gargiulo C et al (2000) Urodynamic findings in boys with posterior urethral valves after treatment with primary valve ablation or vesicostomy and delayed ablation. J Urol 164:139–144
doi: 10.1016/S0022-5347(05)67480-0
pubmed: 10840447
Podesta M, Ruarte AC, Gargiulo C et al (2002) Bladder function associated with posterior urethral valves after primary valve ablation or proximal urinary diversion in children and adolescents. J Urol 168:1830–1835. https://doi.org/10.1097/01.ju.0000030685.14269.0a
doi: 10.1097/01.ju.0000030685.14269.0a
pubmed: 12352370
Anumba DO, Scott JE, Plant ND, Robson SC (2005) Diagnosis and outcome of fetal lower urinary tract obstruction in the northern region of England. Prenat Diagn 25:7–13. https://doi.org/10.1002/pd.1074
doi: 10.1002/pd.1074
pubmed: 15662711
Morris R, Malin G, Khan K, Kilby M (2009) Antenatal ultrasound to predict postnatal renal function in congenital lower urinary tract obstruction: systematic review of test accuracy: Antenatal ultrasound to predict postnatal renal function in LUTO. BJOG 116:1290–1299. https://doi.org/10.1111/j.1471-0528.2009.02194.x
doi: 10.1111/j.1471-0528.2009.02194.x
pubmed: 19438489
Holmdahl G, Sillen U (2005) Boys with posterior urethral valves: outcome concerning renal function, bladder function and paternity at ages 31 to 44 years. J Urol 174:1031–1034. https://doi.org/10.1097/01.ju.0000170233.87210.4f
doi: 10.1097/01.ju.0000170233.87210.4f
pubmed: 16094041
Pieretti RV (1993) The mild end of the clinical spectrum of posterior urethral valves. J Pediatr Surg 28:701–704. https://doi.org/10.1016/0022-3468(93)90036-K
doi: 10.1016/0022-3468(93)90036-K
pubmed: 8340863
Calderon-Margalit R, Golan E, Twig G et al (2018) History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease. N Engl J Med 378:428–438. https://doi.org/10.1056/NEJMoa1700993
doi: 10.1056/NEJMoa1700993
pubmed: 29385364